Lonza Licenses Biotech to Roche

19:38 PM | January 10, 2007 | Chemical Week Editorial Staff

Lonza says it has agreed to license its glutamine synthetase (GS) expression system and GS-CHO protein free system to Roche for the manufacture of therapeutic recombinant proteins and monoclonal...